Glaukos Corp. (GKOS)
134.26
-1.01
(-0.75%)
USD |
NYSE |
May 07, 16:00
134.26
0.00 (0.00%)
Pre-Market: 20:00
Glaukos Research and Development Expense (Annual) : 150.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intuitive Surgical, Inc. | 1.312B |
| Globus Medical, Inc. | 146.94M |
| Insulet Corp. | 301.10M |
| iRhythm Holdings, Inc. | 84.61M |
| Plus Therapeutics, Inc. | 8.379M |